Literature DB >> 2866204

Identification of a homogeneous class of beta 2-adrenoceptors in human platelets by (-)-125I-iodopindolol binding.

X L Wang, O E Brodde.   

Abstract

The highly specific beta-adrenoceptor radioligand (-)-125I-iodopindolol (IPIN) was used to label in membranes from human platelets beta-adrenoceptors. Binding of IPIN was at 25 degrees C saturable (Bmax = 7.4 +/- 2.5 fmoles bound/mg protein, N = 10) of high affinity (KD-value = 34.8 +/- 3.3 pM, N = 10), rapid and reversible. beta-Adrenoceptor antagonists inhibited binding of IPIN with monophasic displacement curves and pseudo Hill coefficients (nH) not significantly different from 1.0. The beta 2-selective antagonist ICI 118,551 was much more potent in inhibiting IPIN binding than the beta 1-selective antagonist bisoprolol. IPIN binding was stereospecific as indicated by the 100-times greater potencies of (-)-alprenolol and (-)-isoprenaline in inhibiting binding than their (+)-isomers. beta-Adrenoceptor agonists inhibited binding with slightly shallow displacement curves and nH-values of 0.85-0.88; the order of potency was: isoprenaline greater than adrenaline greater than noradrenaline. These results demonstrate that IPIN labels (in human platelet membranes with high affinity) a homogeneous population of beta 2-adrenoceptors with low capacity.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2866204

Source DB:  PubMed          Journal:  J Cyclic Nucleotide Protein Phosphor Res        ISSN: 0746-3898


  3 in total

1.  Does treatment with beta-adrenoceptor antagonists in vivo alter human adenylate cyclase responsiveness in vitro?

Authors:  M C Michel; M Klüppel; T Philipp; O E Brodde
Journal:  Br J Clin Pharmacol       Date:  1991-07       Impact factor: 4.335

2.  Is the human platelet beta 2 adrenoceptor coupled to adenylate cyclase?

Authors:  N Cook; S R Nahorski; C Jagger; D B Barnett
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-02       Impact factor: 3.000

3.  Human platelet beta 2-adrenoceptors: agonist-induced internalisation and down-regulation in intact cells.

Authors:  N Cook; S R Nahorski; D B Barnett
Journal:  Br J Pharmacol       Date:  1987-11       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.